top of page



Hopehead Explainer: When is it time to commission source enquiries?
This Hopehead Explainer delves into how and when it makes sense to use source enquiries in your due diligence process and how to avoid some of the major pitfalls.

Wil James


Hopehead Explainer: How to cut through business intelligence jargon
How do you wade through the business intelligence jargon to ensure that you find a provider who will actually be able to meet your specific needs? This Hopehead Explainer seeks to demystify some common terms...

Alex Leslie


Talking Points: Why is CEO departure such a perennial fascination to investors?
The manner of a CEO’s departure is a prism through which we can peek – albeit briefly – behind the corporate veil to understand something of the human dynamics that influence corporate success or failure.

Wil James


Talking Points: Is this the end for anti-corruption investigation?
With the suspension of FCPA, is the SFO now really likely to proceed against corrupt businesses? And is the UK government likely to grant fu

Alex Leslie


Talking Points: Are AI's answers as reliable as they seem?
There are undoubted applications for large language models and other forms of artificial intelligence in accelerating the analysis and colla

Alex Leslie


Talking Points: Where are the Gaps in Senior Hire Diligence?
The resignation of BP boss Bernard Looney throws the spotlight on what companies can and should find out about senior appointments One of the most interesting questions stirred up by Bernard Looney’s resignation is what information the board sought about his reputation for “romantic endeavours with colleagues”, amid allegations in The Times that Looney had “clearly been given a pass and now it has come back to bite them” . This situation has consequences for the boards of oth

Wil James


Putting the "due" in due diligence
Financial institutions that did business with Jeffrey Epstein are reportedly braced for a flood of lawsuits from his alleged victims,...

Alex Leslie


Damage by association: Prevention is better than cure
I hadn't really spotted the link between Jeremy Clarkson and corporate governance risk, but this article makes a good case for why boards...

Wil James
bottom of page